Comparison of short-term therapeutic effect and prognosis between levosimendan and milrinone on pa-tients with decompensated heart failure
10.3969/j.issn.1008-0074.2018.02.19
- VernacularTitle:左西孟旦与米力农治疗失代偿性心力衰竭的近期疗效及预后比较
- Author:
Yu-Gang ZOU
1
;
Mao-Yong YANG
;
Ting-Ting WANG
;
Jia-Jun SUN
Author Information
1. 聊城市第二人民医院ICU(心血管重症)室
- Keywords:
Heart failure;
Natriuretic peptide;
brain;
Levosimendan;
Milrinone
- From:
Chinese Journal of cardiovascular Rehabilitation Medicine
2018;27(2):188-191
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To observe short-term therapeutic effect and prognosis of levosimendan or milrinone on patients with decompensated heart failure(DHF).Methods:A total of 120 DHF patients treated in our hospital were equal-ly divided into levosimendan group(received levosimendan based on routine anti-HF treatment)and milrinone group (received milrinone based on routine anti-HF treatment),both groups were treated for one week continuously.Lev-el of brain natriuretic peptide(BNP),left ventricular ejection fraction(LVEF)and 6min walking distance(6MWD) were compared between two groups before and after treatment.Results:Compared with before treatment,on one week after treatment,there was significant reduction in BNP level and significant rise in LVEF in two groups,P=0.001 all;compared with milrinone group after one-week treatment,there was significant reduction in BNP level [(224.45 ± 29.45)pg/ml vs.(197.41 ± 27.65)pg/ml]and significant rise in LVEF[(37.72 ± 2.03)% vs.(44.33 ± 1.94)%]in levosimendan group,P=0.001 both.Compared with before treatment after three-month treatment, there was significant rise in 6MWD in two groups(P=0.001),and 6MWD of levosimendan group was significantly longer than that of milrinone group[(441.76 ± 75.45)m vs.(409.63 ± 73.56)m],P=0.02. Conclusion:Short-term therapeutic effect and prognosis of routine anti-HF medication combined levosimendan are significantly better than those of combined milrinone treatment in DHF patients.
